Skip to main content

Table 4 Effect of Piperonal on Plasma lipid profiles in normal and experimental obese rats

From: Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats

Groups TC (mg/dl) TG (mg/dl) HDL (mg/dl) LDL (mg/dl) VLDL (mg/dl) Phospholipids (mg/dl) Free fatty acids (mg/dl)
ND control 113.5±11.4 130.6±6.6 50.0±3.1 50.8±4.6 35.7±2.2 85.7±5.3 64.6±5.1
HFD control 311.1±20.2 a* 259.5±8.5 a* 26.6±2.9 a* 130.8±5.9 a* 81.7±4.1 a* 147.9±5.7 a* 116.1±4.6 a*
HFD + Orlistat5mg/kg b.wt 142.6±9.8 b* 136.6±11.1 b* 46.8±3.4 b* 55.8±5.5 b* 41.6±4.4 b* 100.3±5.2 b* 71.2±4.3 b*
HFD+ Piperonal 20 mg/kg b.wt 254.0±9.8 214.0±9.4 31.3±2.4 118.8±9.6 84.7±3.7 135.3±4.3 106.4±5.2
HFD+ Piperonal 30 mg/kg b.wt 211.0±8.2 188.5±10.4 38.7±2.1 94.7±5.8 74.1±4.6 113.2±10.6 88.6±7.6
HFD+ Piperonal 40 mg/kg b.wt 158.3±9.8 b* 145.8±10.1 b* 46.4±5.1 b* 53.1±5.3 b* 46.7±4.7 b* 97.9±5.3 b* 68.1±5.1 b*
  1. Values are statistically significant at *p < 0.05
  2. aSignificantly different from normal control
  3. bSignificantly different from HFD control